Y-PRIT

Serial Number 79377531
Registration 7470437
700

Registration Progress

Application Filed
Jun 20, 2023
Under Examination
Approved for Publication
May 28, 2024
Published for Opposition
May 28, 2024
Registered
Aug 13, 2024

Trademark Image

Y-PRIT

Basic Information

Serial Number
79377531
Registration Number
7470437
Filing Date
June 20, 2023
Registration Date
August 13, 2024
Published for Opposition
May 28, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 13, 2024
Registration
Registered
Classes
005 042

Rights Holder

Y-mAbs Therapeutics, Inc

03
Address
230 Park Avenue, Suite 3350
New York NY 10169
US

Ownership History

Y-mAbs Therapeutics, Inc

Original Applicant
03
US

Y-mAbs Therapeutics, Inc

Owner at Publication
03
US

Y-mAbs Therapeutics, Inc

Original Registrant
03
US

Legal Representation

Attorney
Andrew N. Spivak

USPTO Deadlines

Next Deadline
1686 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240813)
Due Date
August 13, 2030
Grace Period Ends
February 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Nov 20, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 18, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Oct 2, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 2, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Feb 22, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 5, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 5, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Nov 14, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Aug 13, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 13, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 30, 2024 CORR I CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Loading...
May 28, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 28, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 8, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 6, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Apr 30, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 22, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 19, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 19, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 19, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 2, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 2, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 15, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 14, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 5, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 31, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
Class 042
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis services and industrial research services in the field of antibodies

Classification

International Classes
005 042